Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder
Objective: To describe the efficacy of the propantheline bromide inneurogenic bladder in HTLV-I infected patients. Methods: From January/2001 to February/2004, twenty-one HTLV-I-carriers (7 men and 14 women)were selected for treatment with propantheline bromide 15 mg, PO, 2 to 3times a day for 3 mon...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2005-12-01
|
| Series: | Einstein (São Paulo) |
| Subjects: | |
| Online Access: | http://www.einstein.br/revista/biblioteca/artigos/vol3/num_4/Vol3_N4_P251.pdf |
| _version_ | 1818346513706778624 |
|---|---|
| author | Néviton Matos de Castro Daniel Meira Freitas Waldyr Rodrigues Jr Paulo Oliveira André Muniz Edgar Marcelino de Carvalho |
| author_facet | Néviton Matos de Castro Daniel Meira Freitas Waldyr Rodrigues Jr Paulo Oliveira André Muniz Edgar Marcelino de Carvalho |
| author_sort | Néviton Matos de Castro |
| collection | DOAJ |
| description | Objective: To describe the efficacy of the propantheline bromide inneurogenic bladder in HTLV-I infected patients. Methods: From January/2001 to February/2004, twenty-one HTLV-I-carriers (7 men and 14 women)were selected for treatment with propantheline bromide 15 mg, PO, 2 to 3times a day for 3 months, not discontinuing in the follow-up. At the end ofthe treatment period, patients were revaluated through specificquestionnaires for urinary symptoms (UDI) and quality of life (Ditrovie).Results: From the 21 patients enrolled, 15 (71.4%) presented importantclinical improvement, referring decrease of urinary frequency, urgencyand loss, nocturia, and even total control of the dysfunction. Conclusion:We observed an efficient response to the anticholinergic agentpropantheline bromide in urinary dysfunction caused by the HTLV-I. |
| first_indexed | 2024-12-13T17:19:28Z |
| format | Article |
| id | doaj.art-cc38e38dc83e42aaa12335921375c41f |
| institution | Directory Open Access Journal |
| issn | 1679-4508 |
| language | English |
| last_indexed | 2024-12-13T17:19:28Z |
| publishDate | 2005-12-01 |
| publisher | Instituto Israelita de Ensino e Pesquisa Albert Einstein |
| record_format | Article |
| series | Einstein (São Paulo) |
| spelling | doaj.art-cc38e38dc83e42aaa12335921375c41f2022-12-21T23:37:20ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)1679-45082005-12-0134251254Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladderNéviton Matos de CastroDaniel Meira FreitasWaldyr Rodrigues JrPaulo OliveiraAndré MunizEdgar Marcelino de CarvalhoObjective: To describe the efficacy of the propantheline bromide inneurogenic bladder in HTLV-I infected patients. Methods: From January/2001 to February/2004, twenty-one HTLV-I-carriers (7 men and 14 women)were selected for treatment with propantheline bromide 15 mg, PO, 2 to 3times a day for 3 months, not discontinuing in the follow-up. At the end ofthe treatment period, patients were revaluated through specificquestionnaires for urinary symptoms (UDI) and quality of life (Ditrovie).Results: From the 21 patients enrolled, 15 (71.4%) presented importantclinical improvement, referring decrease of urinary frequency, urgencyand loss, nocturia, and even total control of the dysfunction. Conclusion:We observed an efficient response to the anticholinergic agentpropantheline bromide in urinary dysfunction caused by the HTLV-I.http://www.einstein.br/revista/biblioteca/artigos/vol3/num_4/Vol3_N4_P251.pdfHuman T-lymphotropic virus 1Paraparesistropical spasticCholinergic antagonistsBladderneurogenic |
| spellingShingle | Néviton Matos de Castro Daniel Meira Freitas Waldyr Rodrigues Jr Paulo Oliveira André Muniz Edgar Marcelino de Carvalho Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder Einstein (São Paulo) Human T-lymphotropic virus 1 Paraparesis tropical spastic Cholinergic antagonists Bladder neurogenic |
| title | Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder |
| title_full | Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder |
| title_fullStr | Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder |
| title_full_unstemmed | Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder |
| title_short | Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder |
| title_sort | clinical efficacy of an anticolinergic agent in ham tps patients with neurogenic bladder |
| topic | Human T-lymphotropic virus 1 Paraparesis tropical spastic Cholinergic antagonists Bladder neurogenic |
| url | http://www.einstein.br/revista/biblioteca/artigos/vol3/num_4/Vol3_N4_P251.pdf |
| work_keys_str_mv | AT nevitonmatosdecastro clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder AT danielmeirafreitas clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder AT waldyrrodriguesjr clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder AT paulooliveira clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder AT andremuniz clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder AT edgarmarcelinodecarvalho clinicalefficacyofananticolinergicagentinhamtpspatientswithneurogenicbladder |